SK50372006A3 - Process for preparing 7-hydroxy-3,4-dihydrocarbostyril - Google Patents

Process for preparing 7-hydroxy-3,4-dihydrocarbostyril Download PDF

Info

Publication number
SK50372006A3
SK50372006A3 SK5037-2006A SK50372006A SK50372006A3 SK 50372006 A3 SK50372006 A3 SK 50372006A3 SK 50372006 A SK50372006 A SK 50372006A SK 50372006 A3 SK50372006 A3 SK 50372006A3
Authority
SK
Slovakia
Prior art keywords
dihydrocarbostyril
hydroxy
hydrogenation
impurity
carried out
Prior art date
Application number
SK5037-2006A
Other languages
Slovak (sk)
Other versions
SK287896B6 (en
Inventor
Petr Lustig
Josef Jirman
Ludmila Hejtmánková
Original Assignee
Zentiva, A. S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva, A. S. filed Critical Zentiva, A. S.
Publication of SK50372006A3 publication Critical patent/SK50372006A3/en
Publication of SK287896B6 publication Critical patent/SK287896B6/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

The invented process for preparing 7-hydroxy-3,4-dihydrocarbostyril of the general formula IV with purity higher than 98 percent is characterized by execution of a catalytic hydrogenation in order to purify 7-hydroxy-3,4-dihydrocarbostyril from 7-hydroxy carbostyril of the general formula 1.

Description

Oblasť technikyTechnical field

Vynález sa týka spôsobu prípravy vysoko čistého 7-hydroxy-3,4-dihydrokarbostyrilu. Táto zlúčenina sa okrem iného používa ako medziprodukt výroby 7-{4-[4-(2,3-dichlorofenyl)-1 -piperazinyl]butoxy}-3,4-dihydrokarbostyrilu, respektíve 7-{4-[4-(2,3-dichlorofenyl)-l-piperazinyl]butoxy}-l,2,3,4-tetrahydrochinolín-2-ónu známeho pod názvom aripiprazol. Aripiprazol patrí do novej generácie antipsychotík, lebo pôsobí súčasne ako postsynaptický dopamín D2 antagonista a presynaptický dopamín D2 autoreceptorový parciálny agonista.The invention relates to a process for the preparation of highly pure 7-hydroxy-3,4-dihydrocarbostyril. This compound is used, inter alia, as an intermediate for the production of 7- {4- [4- (2,3-dichlorophenyl) -1-piperazinyl] butoxy} -3,4-dihydrocarbostyril and 7- {4- [4- (2, 3-dichlorophenyl) -1-piperazinyl] butoxy} -1,2,3,4-tetrahydroquinolin-2-one known as aripiprazole. Aripiprazole belongs to a new generation of antipsychotics, as it acts simultaneously as a postsynaptic dopamine D2 antagonist and a presynaptic dopamine D2 autoreceptor partial agonist.

Doterajší stav technikyBACKGROUND OF THE INVENTION

Aripiprazol III sa pripravuje podľa postupu EP 0 367 141, ekvivalent US 5 006 528, viď. nasledujúca schéma 1.Aripiprazole III is prepared according to the procedure of EP 0 367 141, equivalent to US 5 006 528, cf. the following scheme 1.

SCHÉMA 1SCHEME 1

Východisková stavebná jednotka 7-(4-halogénbutoxy)-3,4-dihydro-l/7-chinolín-2-ón I sa pripravuje podľa nasledujúcej schémy 2. (EP 0367141, J. Med. Chem. 1998 (41) 658 - 667, Chem. Pharm. Bull. 1988 (36) 4377 - 4388) *HOThe starting unit 7- (4-halobutoxy) -3,4-dihydro-1 H -quinolin-2-one I is prepared according to the following scheme 2. (EP 0367141, J. Med. Chem. 1998 (41) 658 - 667, Chem Pharm Bull 1988 (36) 4377-4388) HO

X = Br,Cl Y = Br,ClX = Br, Cl Y = Br, Cl

SCHÉMA 2SCHEME 2

X '0 * · · • » • · · ·»· ··« « · ·»» · ···«X '0 * · • • »'« '' '' '

-> · ·· ·····«· ·· « · · · · ···« '*'< ·«· · · · ·-> · · · · · «· · '' '' '' '' '' ''

Bežným spôsobom syntézy 7-hydroxy-3,4-dihydrokarbostyrilu IV je postup podľaA common method of synthesizing 7-hydroxy-3,4-dihydrocarbostyril IV is by the following procedure

Chem. Ber. 1927 (60) 858 - 864 (Schéma 3). Podľa tohto postupuje najprv v prvom kroku pripravený 3-chlór-3'-hydroxypropioanilid VI reakciou 3-aminofenolu VII s 3-chlórpropionylchloridom VIII v roztoku acetónu a v druhom kroku reaguje 3-chlór-3'-hydroxypropioanilid s chloridom hlinitým, sodným a draselným za vzniku 7-hydroxy-3,4-dihydrokarbostyrilu IV.Chem. Ber. 1927 (60) 858-864 (Scheme 3). Accordingly, in the first step the 3-chloro-3'-hydroxypropioanilide VI prepared by reacting 3-aminophenol VII with 3-chloropropionyl chloride VIII in acetone solution and in the second step reacting 3-chloro-3'-hydroxypropioanilide with aluminum, sodium and potassium chloride formation of 7-hydroxy-3,4-dihydrocarbostyril IV.

HO'HO '

SCHÉMA 3SCHEME 3

Ďalší postup prípravy 7-hydroxy-3,4-dihydrokarbostyrilu IV bol opísaný v roku 1969 v časopise J. Chem. Soc. Využíva Schmidtovu reakciu cyklického ketónu IX s azidom sodným v prostredí 93 % kyseliny sírovej (Schéma 4). Vzhľadom na vznik nežiaduceho izoméru X, ktorý znižuje výťažok požadovaného 7-hydroxy-3,4-dihydrokarbostyrilu IV a komplikuje jeho izoláciu v požadovanej kvalite, však táto reakcia nie je vhodná. Reakcia je ďalej problematická z hľadiska technologizácie. Výroba je zložitá vzhľadom na ťažkosti zaistenia bezpečnosti práce s azidom sodným a koncentrovanou kyselinou sírovou. V neposlednom rade je táto príprava nevhodná kvôli vzniku veľkého množstva ťažko likvidovateľných odpadov.A further procedure for the preparation of 7-hydroxy-3,4-dihydrocarbostyril IV was described in 1969 in J. Chem. Soc. It utilizes the Schmidt reaction of cyclic ketone IX with sodium azide in 93% sulfuric acid (Scheme 4). However, due to the formation of the undesired isomer X, which reduces the yield of the desired 7-hydroxy-3,4-dihydrocarbostyril IV and complicates its isolation at the desired quality, this reaction is not appropriate. Furthermore, the reaction is problematic in terms of technology. Production is complicated due to the difficulty of ensuring the safety of working with sodium azide and concentrated sulfuric acid. Last but not least, this preparation is unsuitable because of the large amount of waste that can be disposed of.

SCHÉMA 4SCHEME 4

Experimentálne bolo zistené, že postupom podľa Chem. Ber. 1927 (60) 858 - 864 (Príklady 1 a 2) vzniká silne znečistený produkt 7-hydroxy-3,4-dihydrokarbostyril IV. Podľa ·> οExperimentally it was found that following the procedure of Chem. Ber. 1927 (60) 858-864 (Examples 1 and 2), a highly contaminated 7-hydroxy-3,4-dihydrocarbostyril IV product is formed. According to ·> ο

HPLC analýzy produkt IV obsahoval 2 % nečistoty, ktorá bola identifikovaná pomocou LC-MS ako látka s molekulovou hmotnosťou nižšou o 2 jednotky než produkt, to znamená, že nečistotou je 7-hydroxykarbostyril 1.HPLC analysis product IV contained 2% impurity, which was identified by LC-MS as a molecular weight lower than 2 units than the product, i.e. the impurity is 7-hydroxycarbostyril 1.

HO N XOHO N X O

HH

To bolo tiež potvrdené z NMR spektier vzorky, ktorá obsahovala väčšie množstvo tejto nečistoty (6 %). Obsah nečistoty 1 kolísal obvykle od 2 do 10 % pri jednotlivých pokusoch.This was also confirmed from the NMR spectra of a sample that contained a larger amount of this impurity (6%). The impurity 1 content usually varied from 2 to 10% in individual experiments.

Ďalej bolo preukázané, že ak je použitý takto znečistený 7-hydroxy-3,4-dihydrokarbostyril IV na prípravu aripiprazolu, indukuje nečistota 1 v nasledujúcich syntéznych krokoch vznik ďalších nečistôt, ako sú napríklad nečistoty 2, 3, 4. Výsledný aripiprazol je tak získaný v nízkom výťažku aj čistote a nie je teda vhodný na použitie vo farmaceutickom priemysle.Furthermore, it has been shown that when so contaminated 7-hydroxy-3,4-dihydrocarbostyril IV is used for the preparation of aripiprazole, impurity 1 induces further impurities such as impurities 2, 3, 4 in subsequent synthesis steps. The resulting aripiprazole is thus obtained in low yield and purity and is therefore not suitable for use in the pharmaceutical industry.

X=Br, ClX = Br, Cl

Na odstránenie alebo výrazné zníženie obsahu nečistoty 1 v surovom 7-hydroxy-3,4-dihydrokarbostyrile boli uskutočňované iba neúspešné pokusy spočívajúce v kryštalizácii z nasledujúcich rozpúšťadiel: voda, etylacetát, 80 % vodný etanol, 1-butanol, izobutylmetylketón, metanol, 2-propanol, etanol, dichlórmetán a ich zmesi. Ďalej boli skúšané, tiež neúspešne, derivatizácie 3,4- dvojitej väzby 7-hydroxykarbostyrilu jej hydroxyláciou, prípadne bromáciou alebo hydrogenáciou za normálneho tlaku.To remove or significantly reduce the impurity 1 content in the crude 7-hydroxy-3,4-dihydrocarbostyril, only unsuccessful crystallization experiments were performed consisting of the following solvents: water, ethyl acetate, 80% aqueous ethanol, 1-butanol, isobutylmethylketone, methanol, 2- propanol, ethanol, dichloromethane and mixtures thereof. Furthermore, derivatization of the 3,4-double bond of 7-hydroxycarbostyril by its hydroxylation, optionally by bromination or hydrogenation under normal pressure, was also attempted, unsuccessfully.

Problém znečistenia 7-hydroxy-3,4-dihydrokarbostyrilu IV zlúčeninou 7-hydroxykarbostyril 1 rieši nový spôsob prípravy vysoko čistého 7-hydroxy-3,4-dihydrokarbostyrilu IV, ktorý je predmetom vynálezu.The problem of contamination of 7-hydroxy-3,4-dihydrocarbostyril IV with 7-hydroxycarbostyril 1 solves the novel process for the preparation of the highly pure 7-hydroxy-3,4-dihydrocarbostyril IV object of the invention.

Λ -Podstata vynálezu- Summary of the Invention

Podstatou vynálezu je spôsob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu IV s čistotou vyššou než 98 %, ktorý je možné okrem iného použiť ako medziprodukt výroby 7-{4-[4-(2,3-dichlorofenyl)-l-piperazinyl]butoxy}-3,4-dihydrokarbostyrilu, respektíve 7-{4-[4-(2,3—dichlorofenyl)-l-piperazinyl]butoxy}-l,2,3,4-tetrahydrochinolín-2-ónu známeho pod názvom aripiprazol. Postup podľa vynálezu je založený na efektívnom čistení 7-hydroxy-3,4-dihydrokarbostyrilu IV, ktoré spočíva v selektívnej redukcii dvojitej väzby nečistoty 7-hydroxykarbostyrilu 1, ktorá je uskutočňovaná katalytickou hydrogenáciou, najmä hydrogenáciou plynným vodíkom za katalýzy Pd na aktívnom uhlí. Takto je získaný veľmi čistý 7-hydroxy-3,4-dihydrokarbostyril, ktorý môže byť použitý na prípravu farmaceutickej substancie aripiprazol.SUMMARY OF THE INVENTION The present invention provides a process for the preparation of 7-hydroxy-3,4-dihydrocarbostyril IV having a purity of greater than 98%, which can be used inter alia as an intermediate of production of 7- {4- [4- (2,3-dichlorophenyl) -1-piperazinyl ] butoxy} -3,4-dihydrocarbostyril and 7- {4- [4- (2,3-dichlorophenyl) -1-piperazinyl] butoxy} -1,2,3,4-tetrahydroquinolin-2-one, respectively known as aripiprazole. The process according to the invention is based on the effective purification of 7-hydroxy-3,4-dihydrocarbostyril IV, which consists in the selective reduction of the double bond of the impurity 7-hydroxycarbostyril 1 by catalytic hydrogenation, in particular hydrogenation by hydrogen gas under catalysis of Pd on activated carbon. Thus, very pure 7-hydroxy-3,4-dihydrocarbostyril is obtained, which can be used to prepare the pharmaceutical substance aripiprazole.

Po rade neúspešných pokusov o vyčistenie 7-hydroxy-3,4-dihydrokarbostyrilu pomocou kryštalizácie z rôznych rozpúšťadiel a derivatizácie 3,4-dvojitej väzby 7-hydroxykarbostyrilu jej hydroxyláciou, prípadne bromáciou alebo hydrogenáciou za normálneho tlaku sa ukázala jediným efektívnym riešením na prípravu čistého aripiprazolu selektívna redukcia dvojitej väzby.After a series of unsuccessful attempts to purify 7-hydroxy-3,4-dihydrocarbostyril by crystallization from various solvents and derivatizing the 3,4-double bond of 7-hydroxycarbostyril by its hydroxylation or bromination or hydrogenation under normal pressure, it has proven to be the only effective solution for preparing pure aripiprazole. selective reduction of the double bond.

V literatúre sú opísané len redukcia na karbostyrile, nie na 7-hydroxykarbostyrile. Z redukcií na karbostyrile sú opísané tieto spôsoby: elektrochemická redukcia na Ni katóde (Helv. Chim. Acta 32, 1949, 1278), redukcia sodíkom vmetanole, pri ktorej vzniká perhydrochinolín (Chem. Ber. 19, 1886, 3302), redukcia sodíkovým amalgámom v etanole (Chem. Ber. 20, 1887, 2012), redukcia horčíkom v metanole, ktorá však dáva len 30 % výťažok (J. Chem. Soc. Perkin Transl, 1981, 2912). Z hydrogenačných metód prevodu karbostyrilu na 3,4-dihydrokarbostyril je opísaná redukcia vodíkom s katalýzou oxidu platičitého (Heterocycles 28 (2), 1989, 1085). Žiadny z týchto skôr opísaných spôsobov však nevykazoval dostatočný účinok pri čistení 7-hydroxy-3,4-dihydrokarbostyrilu.Only reduction to carbostyril, not to 7-hydroxycarbostyril, is described in the literature. Among the reductions to carbostyril, the following methods are described: electrochemical reduction on Ni cathode (Helv. Chim. Acta 32, 1949, 1278), sodium reduction in methanol to produce perhydroquinoline (Chem. Ber. 19, 1886, 3302), sodium amalgam reduction in ethanol (Chem. Ber. 20, 1887, 2012), reduction with magnesium in methanol, but yielding only a 30% yield (J. Chem. Soc. Perkin Transl, 1981, 2912). Hydrogenation methods of converting carbostyril to 3,4-dihydrocarbostyril have described hydrogen reduction with platinum oxide catalysis (Heterocycles 28 (2), 1989, 1085). However, none of the above-described methods showed a sufficient effect in the purification of 7-hydroxy-3,4-dihydrocarbostyril.

Zďaleka najvýhodnejším spôsobom čistenia 7-hydroxy-3,4-dihydrokarbostyrilu sa prekvapivo ukázala selektívna hydrogenácia plynným vodíkom za katalýzy Pd na aktívnom uhlí (podľa Príkladu 3). Pri vhodne zvolených reakčných podmienkach táto metóda poskytla intermediát s čistotou 99,7 % a s obsahom nečistoty 1 0,04%. Vhodným prostredím na uskutočnenie hydrogenácie sa ukázali Ci až C4 alkoholy, najmä potom metanol. Účinným katalyzátorom reakcie bol Pd katalyzátor na aktívnom uhlí s obsahom paládia 1 - 10 % pri koncentrácii katalyzátora v reakčnej zmesi 1-10 hmôt. %, najmä potom pri koncentrácii 4 hmôt. % v reakčnej zmesi a s obsahom Pd 1,5 %. Plynný vodík je možné do reakčnej zmesi privádzať pod tlakom 0,1 - 10 MPa, počas 3-10 hod a pri teplote 40 - 100 °C, výhodne pri tlaku 3-4 MPa, počas 7 hod a pri teplote 70 - 80 °C.Surprisingly, by far the most preferred method of purification of 7-hydroxy-3,4-dihydrocarbostyril has been the selective hydrogenation of hydrogen gas with Pd on activated carbon (according to Example 3). Under suitably selected reaction conditions, this method gave an intermediate having a purity of 99.7% and an impurity content of 1.04%. C 1 -C 4 alcohols, especially methanol, have been found to be suitable for the hydrogenation. An effective catalyst for the reaction was a Pd catalyst on activated carbon with a palladium content of 1-10% at a catalyst concentration in the reaction mixture of 1-10 wt. %, in particular at a concentration of 4% by weight. % in the reaction mixture and having a Pd content of 1.5%. Hydrogen gas can be introduced into the reaction mixture under a pressure of 0.1-10 MPa, for 3-10 hours and at a temperature of 40-100 ° C, preferably at a pressure of 3-4 MPa, for 7 hours and at a temperature of 70-80 ° C. .

Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION

Príklad 1Example 1

Príprava 3-chlór-3 '-hydroxypropioaniliduPreparation of 3-chloro-3'-hydroxypropioanilide

3-Aminofenol VII (0,4 mol) bol rozpustený v 40 ml sušeného acetónu a pod spätným chladičom za chladenia na vodnom kúpeli bol do roztoku prikvapkávaný roztok 3-chlórpropionylchloridu VIII (0,2 mol) v 40 ml sušeného acetónu. Suspenzia bola zahriata na 50 °C a po 1 hodine miešania bola reakčná zmes naliata do 300 ml IM kyseliny chlorovodíkovej. Bolo pridaných 150 ml vody a zmes bola miešaná pri laboratórnej teplote. Vylúčené kryštály boli odsaté a sušené pri 90 °C. Takto bolo získaných 30 g 3-chlór-3'-hydroxypropioanilidu VI (75 % teória) s teplotou topenia 134 - 135 °C.3-Aminophenol VII (0.4 mol) was dissolved in 40 ml of dried acetone and a solution of 3-chloropropionyl chloride VIII (0.2 mol) in 40 ml of dried acetone was added dropwise to the solution while cooling in a water bath. The suspension was heated to 50 ° C and after stirring for 1 hour, the reaction mixture was poured into 300 mL of 1M hydrochloric acid. 150 ml of water was added and the mixture was stirred at room temperature. The precipitated crystals were aspirated and dried at 90 ° C. 30 g of 3-chloro-3'-hydroxypropioanilide VI (75% of theory), m.p.

Príklad 2Example 2

Príprava 7-hydroxy-3,4-dihydrokarbostyriluPreparation of 7-hydroxy-3,4-dihydrocarbostyril

3-Chlór-3'-hydroxypropioanilid VI (0,15 mol), chlorid hlinitý (1,15 mol), chlorid sodný (0,3 mol) a chlorid draselný (0,26 mol) boli zmiešané a zahrievané na olejovom kúpeli pri teplote 155 až 160 °C počas jednej hodiny. Potom bola zmes odstavená z kúpeľa a do zmesi bolo za miešania naliatych 750 g zmesi vody s ľadovou triešťou. Vymiešaním sa vylúčila pevná látka, ktorá bola odsatá a premytá vodou. Po usušení bolo získaných 87 % surového produktu 7-hydroxy-3,4-dihydrokarbostyrilu IV. Surový produkt bol kryštalizovaný zo 120 ml 50 % vodného etanolu s prídavkom aktívneho uhlia. Po filtrácii a ochladení bol vylúčený produkt odsatý a usušený. Bolo získaných 70 % teoretického výťažku 7-hydroxy-3,4-dihydrokarbostyrilu IV s teplotou topenia 237 - 238 °C. Podľa HPLC analýzy tento produkt obsahoval 2 % nečistoty, ktorá bola identifikovaná pomocou LC-MS ako látka s molekulovou hmotnosťou nižšou o 2 jednotky než produkt, to znamená že nečistotou je 7-hydroxykarbostyril 1. Štruktúra bola tiež potvrdená z NMR spektier vzorky, ktorá obsahovala väčšie množstvo tejto nečistoty (6%).3-Chloro-3'-hydroxypropioanilide VI (0.15 mol), aluminum chloride (1.15 mol), sodium chloride (0.3 mol) and potassium chloride (0.26 mol) were mixed and heated in an oil bath at 155-160 ° C for one hour. The mixture was removed from the bath and 750 g of ice-water mixture were poured into the mixture with stirring. Stirring resulted in a solid which was aspirated and washed with water. After drying, 87% of the crude 7-hydroxy-3,4-dihydrocarbostyril IV product was obtained. The crude product was crystallized from 120 ml of 50% aqueous ethanol with the addition of activated carbon. After filtration and cooling, the precipitated product was filtered off with suction and dried. 70% of the theoretical yield of 7-hydroxy-3,4-dihydrocarbostyril IV with a melting point of 237-238 ° C was obtained. According to HPLC analysis, this product contained 2% impurity, which was identified by LC-MS as having a molecular weight lower than 2 units than the product, i.e. the impurity is 7-hydroxycarbostyril 1. The structure was also confirmed from the NMR spectra of the sample containing more of this impurity (6%).

Príklad 3Example 3

Čistenie 7-hydroxy-3,4-dihydrokarbostyriluPurification of 7-hydroxy-3,4-dihydrocarbostyril

2550 g 7-hydroxy-3,4-dihydrokarbostyrilu s obsahom nečistoty 1 (6 % podľa HPLC) bolo rozpustených v 35 1 metanolu. K roztoku bolo pridaných 100 g katalyzátora, ktorý obsahoval 2,35 % Pd (v sušine) na C a 45 % vody. Následná hydrogenácia bola uskutočnená vodíkom za tlaku 3,5 MPa pri teplote 75 - 80 °C v autokláve za miešania počas 7 hodín. Potom bola reakčná zmes samovoľne ochladená, katalyzátor bol odfiltrovaný, filtrát bol zahustený za zníženého tlaku na objem 8 litrov. Po ochladení na -18 °C bol získaný prvý podiel 1978 g (77,5 % teória) s čistotou podľa HPLC analýzy 99,9 %, obsah nečistoty 1 bol 0,04 %.2550 g of 7-hydroxy-3,4-dihydrocarbostyril containing impurity 1 (6% by HPLC) was dissolved in 35 l of methanol. To the solution was added 100 g of catalyst which contained 2.35% Pd (on dry basis) on C and 45% water. Subsequent hydrogenation was performed with hydrogen at 3.5 MPa at 75-80 ° C in an autoclave with stirring for 7 hours. After the reaction mixture was spontaneously cooled, the catalyst was filtered off, and the filtrate was concentrated under reduced pressure to a volume of 8 liters. After cooling to -18 ° C, a first crop of 1978 g (77.5% of theory) was obtained with a purity of 99.9% according to HPLC analysis, an impurity 1 content of 0.04%.

................

Filtrát bol potom zahustený na 1 liter a po ochladení na -18 °C bol získaný druhý podiel 307 g (12 % teória) s čistotou podľa HPLC analýzy 99,1 %, obsah nečistoty 1 bol 0,06 %.The filtrate was then concentrated to 1 liter and, after cooling to -18 ° C, a second crop of 307 g (12% of theory) was obtained with HPLC purity of 99.1%, impurity 1 content of 0.06%.

Spojením oboch podielov bolo získaných 2285 g (89,5 % teória) 7-hydroxy-3,4-dihydrokarbostyrilu s čistotou 99,8 % a obsahom nečistoty 1 0,04 %.Combining both parts yielded 2285 g (89.5% of theory) of 7-hydroxy-3,4-dihydrocarbostyril with a purity of 99.8% and an impurity content of 1.04%.

Claims (6)

1. Spôsob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu vzorca IV s čistotou vyššou než 98 %, vy značujúci sa tým, že sa uskutočňuje katalytická hydrogenácia na vyčistenie od nečistoty 7-hydroxykarbostyrilu vzorca 1A process for the preparation of 7-hydroxy-3,4-dihydrocarbostyril of formula IV having a purity of more than 98%, characterized in that catalytic hydrogenation is carried out to purify the impurity of 7-hydroxycarbostyril of formula 1 2. Spôsob podľa nároku 1 na získanie 7-hydroxy-3,4-dihydrokarbostyrilu IV s čistotou vyššou než 99,5 %.The process of claim 1 for obtaining 7-hydroxy-3,4-dihydrocarbostyril IV with a purity greater than 99.5%. 3. Spôsob podľa nároku 1, vyznačujúci sa tým, že sa katalytická hydrogenácia uskutočňuje plynným vodíkom v prítomnosti kovového katalyzátora.Process according to claim 1, characterized in that the catalytic hydrogenation is carried out with hydrogen gas in the presence of a metal catalyst. 4. Spôsob podľa nároku 3, vyznačujúci sa tým, že sa čistenie 7-hydroxy-3,4-dihydrokarbostyrilu uskutočňuje v roztoku Ci až C,i alkoholu hydrogenáciou plynným vodíkom v prítomnosti 1-10 hmôt. % Pd katalyzátora na aktívnom uhlí s obsahom paládia 1 -10 % pri teplote 40 - 100 °C, tlaku 0,1 -10 MPa počas 3-10 hod.The process according to claim 3, characterized in that the purification of the 7-hydroxy-3,4-dihydrocarbostyril is carried out in a solution of the C 1 to C 1 alcohol by hydrogenation with hydrogen gas in the presence of 1-10 masses. % Pd of activated carbon catalyst with a palladium content of 1 -10% at a temperature of 40-100 ° C, a pressure of 0.1-10 MPa for 3-10 hours. 5. Spôsob podľa nároku 4, vyznačujúci sa tým, že sa hydrogenácia uskutočňuje v metanole za prítomnosti 4 hmôt. % Pd katalyzátora na aktívnom uhlí s obsahom Pd 1,5 %, pri teplote 70 - 80 °C, tlaku 3-4 MPa počas 7 hod.A process according to claim 4, characterized in that the hydrogenation is carried out in methanol in the presence of 4 masses. % Pd of activated carbon catalyst with a Pd content of 1.5%, at a temperature of 70-80 ° C, a pressure of 3-4 MPa for 7 hours. 6. Spôsob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu IV s čistotou vyššou než 99,5 % vyznačujúci sa tým, že6. A process for the preparation of 7-hydroxy-3,4-dihydrocarbostyril IV having a purity greater than 99.5%, characterized in that: a) sa pripraví 3-chlór-3'-hydroxypropioanilid reakciou 3-aminofenolu s 3-chlórpropionylchloridom v roztoku acetónua) 3-chloro-3'-hydroxypropioanilide is prepared by reaction of 3-aminophenol with 3-chloropropionyl chloride in acetone solution b) 3-chlór-3'-hydroxypropioanilid sa nechá reagovať s chloridom hlinitým, sodným a draselným za vzniku surového 7-hydroxy-3,4-dihydrokarbostyrilu IVb) 3-chloro-3'-hydroxypropioanilide is reacted with aluminum, sodium and potassium chloride to give crude 7-hydroxy-3,4-dihydrocarbostyril IV c) surový 7-hydroxy-3,4-dihydrokarbostyrilu IV sa čistí rekryštalizáciouc) the crude 7-hydroxy-3,4-dihydrocarbostyril IV is purified by recrystallization d) rekryštalizovaný 7-hydroxy-3,4-dihydrokarbostyril sa čistí katalytickou hydrogenáciou plynným vodíkom v prostredí Ci až C4 alkoholu.d) the recrystallized 7-hydroxy-3,4-dihydrocarbostyril is purified by catalytic hydrogenation with hydrogen gas in a C 1 -C 4 alcohol medium.
SK5037-2006A 2005-05-26 2006-04-07 Process for preparing 7-hydroxy-3,4-dihydrocarbostyril SK287896B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20050338A CZ300351B6 (en) 2005-05-26 2005-05-26 Process for preparing 7-hydroxy-3,4-dihydrocarbostyril

Publications (2)

Publication Number Publication Date
SK50372006A3 true SK50372006A3 (en) 2006-12-07
SK287896B6 SK287896B6 (en) 2012-03-02

Family

ID=37482386

Family Applications (1)

Application Number Title Priority Date Filing Date
SK5037-2006A SK287896B6 (en) 2005-05-26 2006-04-07 Process for preparing 7-hydroxy-3,4-dihydrocarbostyril

Country Status (2)

Country Link
CZ (1) CZ300351B6 (en)
SK (1) SK287896B6 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104356063A (en) * 2014-10-16 2015-02-18 华东师范大学 Preparation method of 7-hydroxy-3,4-dihydro-2-(1H) carbostyril
CN109776408B (en) * 2017-11-14 2022-12-20 上海医药工业研究院 Preparation method of 7-hydroxy-2-quinolinone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48103590A (en) * 1972-04-13 1973-12-25
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JPH07247271A (en) * 1994-01-21 1995-09-26 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril derivative
JP4232211B2 (en) * 1998-03-19 2009-03-04 エア・ウォーター株式会社 Method for producing 3,4-dihydrocarbostyrils

Also Published As

Publication number Publication date
CZ300351B6 (en) 2009-04-29
CZ2005338A3 (en) 2007-01-17
SK287896B6 (en) 2012-03-02

Similar Documents

Publication Publication Date Title
CN104844585B (en) Method for preparing brexpiprazole
US7902377B2 (en) Method for preparing medetomidine and its salts
EP1480953B1 (en) Process for preparing aripiprazole
CN110240586A (en) The preparation method of 2,3- dihydro -1H- benzo [f] chroman -2- amine derivative
EP1873151B1 (en) Improved process for producing moxonidine
JP4478140B2 (en) Preparation of carbostyril compounds for pharmaceutical use
AU2012264476B2 (en) Process for the preparation of paliperidone
WO2007118923A1 (en) A process for the preparation of aripiprazole and intermediates thereof
SK50372006A3 (en) Process for preparing 7-hydroxy-3,4-dihydrocarbostyril
WO2015111085A2 (en) Processes for the preparation of eltrombopag and pharmaceutically acceptable salts, solvates and intermediates thereof
CA3146869A1 (en) Process for the preparation of a nitric oxide donating prostaglandin analogue
WO2023082839A1 (en) Filgotinib preparation method
CN101137646A (en) Synthesis of ccr5 antagonists
CN107382753B (en) A kind of preparation method of high-purity hydrochloric acid ritodrine
US20100130744A1 (en) Process for the preparation of aripiprazole
JP5065020B2 (en) Process for producing levofloxacin or a hydrate thereof
CN106243050B (en) A kind of method of suitable industrialized production Clobazam
WO2013020672A1 (en) Process for the preparation of aripiprazole
JPH07247271A (en) 3,4-dihydrocarbostyril derivative
CN108069900B (en) Preparation method and application of aripiprazole hydrochloride
CN111100042A (en) Preparation method of 2-methoxy-5-sulfonamide benzoic acid
JP6023770B2 (en) Method for producing anhydrous aripiprazole crystals B
CN108503580A (en) A kind of preparation method of Eliquis intermediate
CN111978264B (en) Industrial production method of deferasirox
JP2001002621A (en) Purification of polyprenyl-based compound

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: ZENTIVA, K.S., PRAHA, DOLNI MECHOLUPY, CZ

Effective date: 20120524

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20190407